期刊文献+
共找到1,037篇文章
< 1 2 52 >
每页显示 20 50 100
Role of spleen tyrosine kinase in liver diseases 被引量:1
1
作者 Dhadhang Wahyu Kurniawan Gert Storm +1 位作者 Jai Prakash Ruchi Bansal 《World Journal of Gastroenterology》 SCIE CAS 2020年第10期1005-1019,共15页
Spleen tyrosine kinase (SYK),a non-receptor tyrosine kinase,is expressed in most hematopoietic cells and non-hematopoietic cells and play a crucial role in both immune and non-immune biological responses.SYK mediate d... Spleen tyrosine kinase (SYK),a non-receptor tyrosine kinase,is expressed in most hematopoietic cells and non-hematopoietic cells and play a crucial role in both immune and non-immune biological responses.SYK mediate diverse cellular responses via an immune-receptor tyrosine-based activation motifs (ITAMs)-dependent signalling pathways,ITAMs-independent and ITAMs-semidependent signalling pathways.In liver,SYK expression has been observed in parenchymal (hepatocytes) and non-parenchymal cells (hepatic stellate cells and Kupffer cells) and found to be positively correlated with the disease severity.The implication of SYK pathway has been reported in different liver diseases including liver fibrosis,viral hepatitis,alcoholic liver disease,non-alcoholic steatohepatitis and hepatocellular carcinoma.Antagonism of SYK pathway using kinase inhibitors have shown to attenuate the progression of liver diseases thereby suggesting SYK as a highly promising therapeutic target.This review summarizes the current understanding of SYK and its therapeutic implication in liver diseases. 展开更多
关键词 spleen tyrosine kinase liver diseases inFLAMMATION Targeted therapeutics spleen tyrosine kinase inhibitors
下载PDF
Liver-spleen axis: Intersection between immunity, infections and metabolism 被引量:13
2
作者 Giovanni Tarantino Antonella Scalera Carmine Finelli 《World Journal of Gastroenterology》 SCIE CAS 2013年第23期3534-3542,共9页
Spleen has been considered a neglected organ so far, even though is strictly linked to liver. The spleen plays an important role in the modulation of the immune system and in the maintenance of peripheral tolerance vi... Spleen has been considered a neglected organ so far, even though is strictly linked to liver. The spleen plays an important role in the modulation of the immune system and in the maintenance of peripheral tolerance via the clearance of circulating apoptotic cells, the differentiation and activation of T and B cells and production of antibodies in the white pulp. Moreover, splenic macrophages are able to remove bacteria from the blood and protect from sepsis during systemic infections. We review the spleen function and its assessment in humans starting from the description of spleen diseases, ranging from the congenital asplenia to secondary hyposplenism. From the literature data it is clear that obesity in humans affects different compartments of immune system, even thought there are still few data available on the implicated mechamisms. The intent is to enable clinicians to evaluate the newly recognized role of metabolic and endocrine functions of the spleen with special emphasis to obesity and nonalcoholic fatty liver disease in the context of the available literature.Moreover, understanding the spleen function could be important to develop appropriate prevention strategies in order to counteract the pandemia of obesity. In this direction, we suggest spleen longitudinal diameter at ultrasonography, as simple, cheap and largely available tool, be used as new marker for assessing splenic function, in the context of the so-called liver-spleen axis. 展开更多
关键词 spleen size Obesity Non-alcoholic FATTY liver disease
下载PDF
Nonalcoholic fatty liver disease, spleen and psoriasis:New aspects of low-grade chronic inflammation 被引量:3
3
作者 Nicola Balato Maddalena Napolitano +3 位作者 Fabio Ayala Cataldo Patruno Matteo Megna Giovanni Tarantino 《World Journal of Gastroenterology》 SCIE CAS 2015年第22期6892-6897,共6页
AIM: To investigate spleen status in psoriasis and itsrelationship with hepatic steatosis, Psoriasis Area and Severity Index, and insulin resistance.METHODS: Seventy-nine psoriatic patients who were not suffering from... AIM: To investigate spleen status in psoriasis and itsrelationship with hepatic steatosis, Psoriasis Area and Severity Index, and insulin resistance.METHODS: Seventy-nine psoriatic patients who were not suffering from any chronic inflammatory disease were retrospectively selected for inclusion in this study,and their complete medical records were accessed.An age- and sex-matched group of 80 non-psoriatic,obese patients was included as a control. The following relevant data were collected: age, sex, weight, height,body mass index, waist circumference, blood pressure,insulin resistance status, age at psoriasis onset, and severity of psoriasis. Abdominal ultrasonography was performed to determine spleen longitudinal diameter(SLD), and hepatic steatosis grade.RESULTS: The SLD of control obese patients was greater than that of psoriatic subjects(P = 0.013),but body mass index predicted the size of the spleen in psoriatic patients(P < 0.001). The SLD of psoriatic patients with normal weight was significantly reduced with respect to the overweight/obese psoriatic patients(P = 0.002). A multiple regression analysis revealed that body mass index was a unique predictor of the spleen size(P < 0.001). Finally, the disease duration predicted the spleen size in psoriatic subjects(P =0.038).CONCLUSION: This study shows a correlation between the SLD and the duration of psoriasis. 展开更多
关键词 HEPATIC STEATOSIS inFLAMMATION nonalcoholicfatty liver disease PSORIASIS spleen size
下载PDF
Beh et's disease complicated by multiple aseptic abscesses of the liver and spleen 被引量:3
4
作者 Keisuke Maeshima Koji Ishii +2 位作者 Megumi Inoue Katsuro Himeno Masataka Seike 《World Journal of Gastroenterology》 SCIE CAS 2013年第20期3165-3168,共4页
Aseptic abscesses are an emergent entity and have been described in inflammatory bowel disease,especially in Crohn's disease,and in other diseases.However,aseptic abscesses associated with Beh et's disease are... Aseptic abscesses are an emergent entity and have been described in inflammatory bowel disease,especially in Crohn's disease,and in other diseases.However,aseptic abscesses associated with Beh et's disease are extremely rare.We report a Japanese male diagnosed with an incomplete type of Beh et's disease who developed multiple aseptic abscesses of the spleen and liver.In 2002,the spleen abscesses were accompanied by paroxysmal oral aphthous ulcers and erythema nodosum.As the patient's response to antibiotic treatment was inadequate,a splenectomy was performed.Severe inflammatory cell infiltration,largely of polymorphonuclear neutrophils,was observed without evidence of bacterial or fungal growth.Although the patient had no history of ocular symptoms or genital ulcers,a diagnosis of incomplete Beh et's disease was made according to the Japanese diagnostic criteria because of the presence of paroxysmal arthritis and epididymitis since 2002.In 2005,multiple liver abscesses developed with right hypochondrial pain and seemed to be attributed to Beh et's disease because the abscesses yielded negative results during a microbiologic investigation and failed to go into remission under antibiotic therapy.Oral prednisone(15 mg/d) was started in May 2006,and the abscesses dramatically disappeared 4 wk after treatment.Although the patient had a relapse of the liver abscesses in association with the tapering of prednisone,the augmentation of prednisone dosage yielded a response.The abscesses of the liver and spleen were strongly suggested to be attributed to Beh et's disease.Clinician should be aware of the existence of aseptic abscesses as uncommon manifestations of Beh et's disease. 展开更多
关键词 Beh et’s disease ASEPTIC ABSCESS spleen liver PREDNISONE
下载PDF
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 被引量:4
5
作者 Federico Ravaioli Antonio Colecchia +7 位作者 Elton Dajti Giovanni Marasco Luigina Vanessa Alemanni Mariarosa Tamè Francesco Azzaroli Stefano Brillanti Giuseppe Mazzella Davide Festi 《World Journal of Hepatology》 CAS 2018年第10期731-742,共12页
AIM To investigate changes in spleen stiffness measurements(SSMs) and other non-invasive tests(NITs) after treatment with direct-acting antivirals(DAAs) and identify predictors of SSM change after sustainedvirological... AIM To investigate changes in spleen stiffness measurements(SSMs) and other non-invasive tests(NITs) after treatment with direct-acting antivirals(DAAs) and identify predictors of SSM change after sustainedvirological response(SVR). METHODS We retrospectively analysed 146 advanced-chronic liver disease(ACLD) patients treated with DAA with available paired SSM at baseline and SVR24. Liver stiffness(LSM), spleen diameter(SD), platelet count(PLT) and liver stiffness-spleen diameter to platelet ratio score(LSPS) were also investigated. LSM ≥ 21 k Pa was used as a cut-off to rule-in clinically significant portal hypertension(CSPH). SSM reduction > 20% from baseline was defined as significant.RESULTS SSM significantly decreased at SVR24, in both patients with and without CSPH; in 44.8% of cases, SSM reduction was > 20%. LSPS significantly improved in the entire cohort at SVR24; SD and PLT changed significantly only in patients without CSPH. LSM significantly decreased in 65.7% of patients and also in 2/3 patients in whom SSM did not decrease. The independent predictor of decreased SSM was median relative change of LSM. CSPH persisted in 54.4% patients after SVR. Delta LSM and baseline SSM were independent factors associated with CSPH persistence.CONCLUSION SSM and other NITs significantly decrease after SVR, although differently according to the patient's clinical condition. SSM faithfully reflects changes in portal hypertension and could represent a useful NIT for the follow-up of these patients. 展开更多
关键词 Clinically significant PORTAL HYPERTENSION spleen STIFFNESS measurement Advanced CHRONIC liver disease Direct-acting ANTIVIRALS PORTAL HYPERTENSION Hepatitis C Non-invasive test
下载PDF
Elastography-based screening for esophageal varices in patients with advanced chronic liver disease 被引量:23
6
作者 Rafael Paternostro Thomas Reiberger Theresa Bucsics 《World Journal of Gastroenterology》 SCIE CAS 2019年第3期308-329,共22页
Elastography-based liver stiffness measurement(LSM) is a non-invasive tool for estimating liver fibrosis but also provides an estimate for the severity of portal hypertension in patients with advanced chronic liver di... Elastography-based liver stiffness measurement(LSM) is a non-invasive tool for estimating liver fibrosis but also provides an estimate for the severity of portal hypertension in patients with advanced chronic liver disease(ACLD). The presence of varices and especially of varices needing treatment(VNT) indicates distinct prognostic stages in patients with compensated ACLD(cACLD). The Baveno VI guidelines suggested a simple algorithm based on LSM < 20 kPa(by transient elastography, TE) and platelet count > 150 G/L for ruling-out VNT in patients with cACLD. These(and other) TE-based LSM cut-offs have been evaluated for VNT screening in different liver disease etiologies. Novel point shear-wave elastography(pSWE) and two-dimensional shear wave elastography(2D-SWE) methodologies for LSM have also been evaluated for their ability to screen for "any" varices and for VNT. Finally, the measurement of spleen stiffness(SSM) by elastography(mainly by pSWE and 2D-SWE) may represent another valuable screening tool for varices. Here, we summarize the current literature on elastography-based prediction of "any" varices and VNT. Finally,we have summarized the published LSM and SSM cut-offs in clinically useful scale cards. 展开更多
关键词 ELASTOGRAPHY liver STIFFNESS spleen STIFFNESS Shear wave Magnetic resonance ELASTOGRAPHY VARICES Portal hypertension Cirrhosis ADVANCED chronic liver disease
下载PDF
Ultrasound imaging of abdominal sarcoidosis: State of the art 被引量:2
7
作者 Claudio Tana Cosima Schiavone +6 位作者 Andrea Ticinesi Fabrizio Ricci Maria Adele Giamberardino Francesco Cipollone Mauro Silingardi Tiziana Meschi Christoph F Dietrich 《World Journal of Clinical Cases》 SCIE 2019年第7期809-818,共10页
Since it has been recognized that sarcoidosis(SA) is not an exclusive disorder of the lungs but can also affect other organs such as the liver and spleen, efforts have been made to define specific imaging criteria for... Since it has been recognized that sarcoidosis(SA) is not an exclusive disorder of the lungs but can also affect other organs such as the liver and spleen, efforts have been made to define specific imaging criteria for the diagnosis of the single organ involvement, and the concept has been reinforced that the exclusion of alternative causes is important to achieve the correct diagnosis. Ultrasound(US)is a useful tool to evaluate patients with suspected abdominal SA, such as of the liver, spleen, kidney, pancreas and other organs, showing findings such as organomegaly, focal lesions and lymphadenopathy. While the diagnosis of abdominal SA is more predictable in the case of involvement of other organs(e.g.,lungs), the problem is more complex in the case of isolated abdominal SA. The recent use of contrast-enhanced ultrasound and endoscopic ultrasound elastography has provided additional information about the enhancement patterns and tissue rigidity in abdominal SA. Here we critically review the role of US in abdominal SA, reporting typical findings and limitations of current evidence and by discussing future perspectives of study. 展开更多
关键词 SARCOIDOSIS SARCOID lesions GRANULOMATOUS disorders liver spleen Rare diseases ULTRASOUND CONTRAST-ENHANCED ULTRASOUND
下载PDF
基于“肝脾同调”阐析慢性肝病的中医治疗 被引量:1
8
作者 叶永安 靳茜 +1 位作者 李小科 杜宏波 《世界中医药》 CAS 北大核心 2024年第5期652-655,共4页
慢性肝病是临床常见疾病,“郁、虚、湿、毒、瘀”是其核心病机,在疾病的不同阶段各有侧重,其中,以“郁、虚”为核心的肝脾失调是慢性肝病发生发展的关键。“肝脾同调”是治疗慢性肝病的基本治法,在慢性肝病不同阶段,其“肝脾同调”内涵... 慢性肝病是临床常见疾病,“郁、虚、湿、毒、瘀”是其核心病机,在疾病的不同阶段各有侧重,其中,以“郁、虚”为核心的肝脾失调是慢性肝病发生发展的关键。“肝脾同调”是治疗慢性肝病的基本治法,在慢性肝病不同阶段,其“肝脾同调”内涵同中有异。根据肝、脾生理病理特性,治脾明辨虚实,厘清轻重,活用运脾、健脾、温脾、醒脾、补脾等法;调肝体用并重,精准辨证,活用疏肝、缓肝、散肝、柔肝等法。临床上,治脾与调肝相辅相成,治调并举,常获良效。 展开更多
关键词 慢性肝病 核心病机 肝脾同病 肝脾同调 治脾调肝 中医治疗
下载PDF
李延从脾胃论治冠心病的临床经验 被引量:2
9
作者 赵志成 刘桉君 《广州中医药大学学报》 CAS 2024年第1期213-218,共6页
冠心病为临床中常见的心血管疾病,可归属中医学的“胸痹”“心痛”等疾病范畴。李延教授认为本病之病性总属本虚标实之证,以脾虚、脾胃健运失常为本,标实在于痰浊、血瘀、气滞、寒凝等有形实邪痹阻心脉。治疗时重视调理脾胃,重用黄芪、... 冠心病为临床中常见的心血管疾病,可归属中医学的“胸痹”“心痛”等疾病范畴。李延教授认为本病之病性总属本虚标实之证,以脾虚、脾胃健运失常为本,标实在于痰浊、血瘀、气滞、寒凝等有形实邪痹阻心脉。治疗时重视调理脾胃,重用黄芪、白术、党参、五味子等健脾养心以治本,结合通阳化浊、活血化瘀、疏肝理气、温阳散寒等治法,标本兼治,通补兼顾,使脾气健旺,心气充沛,瘀去痰消,胸阳得以舒展,则心之血脉恢复畅通,胸痹心痛诸症得到缓解。李延教授从脾胃论治冠心病的经验可为中医临床诊治冠心病提供参考。 展开更多
关键词 冠心病 胸痹 本虚标实 脾虚 痰浊 血瘀 调理脾胃 健脾养心 李延
下载PDF
Treatment for non-alcoholic steatohepatitis with type 2 diabetes by traditional Chinese medicine:a case report and experience
10
作者 Jing Chang Ling-Lan Liu +1 位作者 Qian-Feng Wang Xiang Cui 《Gastroenterology & Hepatology Research》 2023年第2期1-5,共5页
Non-alcoholic fatty liver disease and type 2 diabetes are common comorbidities or target organ damage,which can lead to adverse metabolism and increased risk of cardiovascular and cerebrovascular diseases.In the manag... Non-alcoholic fatty liver disease and type 2 diabetes are common comorbidities or target organ damage,which can lead to adverse metabolism and increased risk of cardiovascular and cerebrovascular diseases.In the management plan of non-alcoholic fatty liver disease and type 2 diabetes,there is no drug with significant efficacy or both.The dialectical idea of traditional Chinese medicine has a good curative effect and significant advantages in treating metabolic disorders.The author now reviewed a case of non-alcoholic steatohepatitis combined with type 2 diabetes.In this case,the method of invigorating the spleen and eliminating turbidity was effective,which effectively prevented the progression of liver disease in the patient,and T2DM was alleviated by maintaining within the standard range after the use of insulin was stopped.It can be said that“killing two birds with one stone”,more fully reflects the advantages of traditional Chinese medicine in the integrated treatment of metabolic-related diseases. 展开更多
关键词 traditional Chinese medicine invigorating spleen and removing turbidity metabolism-related fatty liver disease
下载PDF
内服中药复方治疗非酒精性脂肪性肝病的临床研究进展 被引量:1
11
作者 李艳 刘丽丽 +1 位作者 施卫兵 张国梁 《实用中医内科杂志》 2024年第6期72-75,共4页
近年来,非酒精性脂肪性肝病(NAFLD)的发生率逐年上升,是临床常见的慢性肝病之一,由于其发病机制复杂,现代医学的治疗不仅限于肝脏本身病变,还要控制代谢紊乱。非酒精性脂肪性肝病属于“肝癖”“积聚”“胁痛”等范畴,病位在肝、脾、肾,... 近年来,非酒精性脂肪性肝病(NAFLD)的发生率逐年上升,是临床常见的慢性肝病之一,由于其发病机制复杂,现代医学的治疗不仅限于肝脏本身病变,还要控制代谢紊乱。非酒精性脂肪性肝病属于“肝癖”“积聚”“胁痛”等范畴,病位在肝、脾、肾,病理产物有痰、湿、瘀、热等,为虚实夹杂之病。中医药有着多靶点、多途径、整体调节的优势,现就内服中药复方治疗NAFLD的临床研究进行归纳,发现苓桂术甘汤、五苓散、苦黄颗粒、益肾化痰方、桂附理中汤、养肝消脂茶、大黄利胆胶囊、柴胡疏肝散、柴胡化浊饮等中药复方在改善非酒精性脂肪性肝病患者临床症状、肝功能、脂代谢、肝脏影像学指标、胰岛素抵抗、肠道功能、抗炎、血管性疾病危险因素等方面作用显著。 展开更多
关键词 非酒精性脂肪性肝病 中药 临床研究进展
下载PDF
基于“脾气散精”理论探讨慢性肝病的中医治疗
12
作者 王刚 靳茜 +2 位作者 郭紫薇 陈玥 叶永安 《中医药学报》 2024年第1期1-5,共5页
慢性肝病的发病与脾密切相关,“脾气散精”是《黄帝内经》对脾功能的高度概括,脾气散精功能障碍贯穿慢性肝病始终,脾失运化,生湿生痰,瘀血阻络为慢性肝病进展的关键因素。治疗时应将健脾作为慢性肝病的基本治法之一,并根据脾运的不同状... 慢性肝病的发病与脾密切相关,“脾气散精”是《黄帝内经》对脾功能的高度概括,脾气散精功能障碍贯穿慢性肝病始终,脾失运化,生湿生痰,瘀血阻络为慢性肝病进展的关键因素。治疗时应将健脾作为慢性肝病的基本治法之一,并根据脾运的不同状态,配合运脾、醒脾、温脾等不同治法,以复脾气散精之能,病程中尤应抓住瘀血络阻这一关键病机,活血化瘀通络,防止慢性肝病进一步向肝积、鼓胀发展,使脾运得复,瘀阻得除,标本兼治。 展开更多
关键词 慢性肝病 肝纤维化 脾气散精 从脾论治 脾虚不能散精
下载PDF
双叶散治疗脾虚痰瘀型2型糖尿病合并非酒精性脂肪肝病的临床观察
13
作者 周道成 阮贵基 +4 位作者 帅优优 徐文华 刘德亮 赵恒侠 李惠林 《广州中医药大学学报》 CAS 2024年第10期2687-2694,共8页
【目的】观察双叶散治疗脾虚痰瘀型2型糖尿病(T2DM)合并非酒精性脂肪肝病(NAFLD)的临床疗效。【方法】将80例脾虚痰瘀型T2DM合并NAFLD患者随机分为治疗组和对照组,每组各40例。对照组给予西医常规降糖、降脂、护肝降酶治疗,治疗组在对... 【目的】观察双叶散治疗脾虚痰瘀型2型糖尿病(T2DM)合并非酒精性脂肪肝病(NAFLD)的临床疗效。【方法】将80例脾虚痰瘀型T2DM合并NAFLD患者随机分为治疗组和对照组,每组各40例。对照组给予西医常规降糖、降脂、护肝降酶治疗,治疗组在对照组的基础上给予双叶散治疗,疗程为3个月。观察2组患者治疗前后中医证候积分、胰岛素抵抗指数(HOMAIR)、空腹胰岛素(FINS)、空腹血糖(FBG)、餐后2 h血糖(2hPG)、糖化血红蛋白(HbA1C)、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、肝功能及肝脏B超分度的变化情况,并评价2组患者的临床疗效及用药安全性。【结果】(1)疗效方面:治疗3个月后,治疗组的总有效率为85.00%(34/40),对照组为70.00%(28/40),组间比较(χ^(2)检验),治疗组的疗效明显优于对照组(P<0.01)。(2)中医证候积分方面:治疗后,2组患者的形体肥胖、肢体困重、气短懒言、胸闷刺痛、腹胀纳呆等中医证候积分均较治疗前降低(P<0.05),且治疗组对各项中医证候积分的降低幅度均明显优于对照组(P<0.05)。(3)糖脂代谢指标方面:治疗后,2组患者的FINS、HOMA-IR、FBG、2hPG、HbA1C、TC、TG、LDL-C水平均较治疗前明显降低(P<0.05),HDL-C水平均较治疗前明显升高(P<0.05),且治疗组对FINS、HOMA-IR、FBG、2hPG、HbA1C、TC、TG、LDL-C水平的降低幅度及对HDL-C水平的升高幅度均明显优于对照组(P<0.05)。(4)肝功能方面:治疗后,2组患者的丙氨酸氨基转移酶(ALT)、门冬氨酸氨基转移酶(AST)、γ-谷氨酰转肽酶(GGT)水平均较治疗前明显降低(P<0.05),且治疗组对各项肝功能指标的降低幅度均明显优于对照组(P<0.05)。(5)脂肪肝B超分度方面:治疗后,2组患者的脂肪肝B超分度均较治疗前明显改善(P<0.05),且治疗组对脂肪肝B超分度的改善作用明显优于对照组,差异有统计学意义(P<0.05)。(6)安全性方面:治疗过程中,2组患者均无肝肾功能受损及血、尿、大便常规异常等不良反应。【结论】双叶散治疗脾虚痰瘀型T2DM合并NAFLD疗效显著,能减轻患者临床症状,纠正糖脂代谢紊乱,改善肝功能和脂肪肝B超分度。 展开更多
关键词 双叶散 脾虚痰瘀型 2型糖尿病 非酒精性脂肪肝病 糖脂代谢 肝功能
下载PDF
基于肠肝轴理论探讨治未病法在肝癌治疗中的应用
14
作者 方美花 靳永杰 +3 位作者 张晟 刘智慧 胡佳丽 于小伟 《中医肿瘤学杂志》 2024年第3期15-19,共5页
肠道微生物群是生活在人体消化道中的细菌群,与宿主长期相互依存,维持动态平衡关系,与人体健康密切相关。失衡的微生态系统对疾病的发生发展具有一定的促进作用,随着疾病的发生,人体肠道菌群的组成结构、菌群多样化也会随之改变。肠道... 肠道微生物群是生活在人体消化道中的细菌群,与宿主长期相互依存,维持动态平衡关系,与人体健康密切相关。失衡的微生态系统对疾病的发生发展具有一定的促进作用,随着疾病的发生,人体肠道菌群的组成结构、菌群多样化也会随之改变。肠道细菌及其代谢物一方面通过影响肠上皮功能障碍以及胆汁酸代谢影响相关信号通路从而引发肝癌,另一方面通过肠-肝轴循环进入肝脏激活炎症反应相关信号通路从而促进肝癌的进展。中医“治未病”理论提出“见肝之病,知肝传脾,当先实脾”。历代医家在此基础上用“肝病治脾”论治肝病成效显著。现对肠道菌群对肝癌的发生发展机制以及健脾益气方法调节肠道稳态在原发性肝癌治疗机理及运用规律进行总结,为临床治疗肝癌拓宽思路。从中医理论出发,进一步探讨肝-肠轴学说。 展开更多
关键词 肝癌 健脾法 肠肝轴 肠道菌群
下载PDF
汪龙德运用疏肝健脾法从脾胃论治干燥综合征经验
15
作者 杜晓娟 汪龙德 +2 位作者 靳三省 李正菊 毛兰芳 《辽宁中医杂志》 CAS 北大核心 2024年第4期19-21,共3页
介绍汪龙德主任医师运用疏肝健脾法从脾胃论治干燥综合征的临床经验和学术思想。认为干燥综合征的关键病机是肝郁脾虚,发病部位在肝脾,属虚实夹杂证,临证强调运用疏肝健脾法为基本治法,使肝气畅达,疏泄正常,气行血行,则瘀血渐除,气机布... 介绍汪龙德主任医师运用疏肝健脾法从脾胃论治干燥综合征的临床经验和学术思想。认为干燥综合征的关键病机是肝郁脾虚,发病部位在肝脾,属虚实夹杂证,临证强调运用疏肝健脾法为基本治法,使肝气畅达,疏泄正常,气行血行,则瘀血渐除,气机布散津液于全身;脾胃健运,气血津液化生有源,痰饮水湿自化,则清窍腠理得以濡润。辅以清热润燥、养血生津、活血祛瘀,标本同治,可获良效。并结合案例,介绍了疏肝健脾法治疗干燥综合征的应用,以期为临床诊疗提供参考。 展开更多
关键词 干燥综合征 疏肝健脾法 肝郁脾虚 名医经验 汪龙德
下载PDF
基于“肝为罢极之本”诊治心脾疾病验案四则
16
作者 李晨 张庆祥 +2 位作者 蒋馨莹 陆柯 褚翘 《山东中医杂志》 2024年第2期193-196,共4页
“肝为罢极之本”是指通过肝脏的调节,人体各脏腑组织及精气血津液运行皆弛张有度,无太过或不及,以维持中和的状态。若肝脏功能失调,影响全身气机枢转,可导致病理表现截然相反的五脏病变。如肝气疏泄不及,气滞肠腑,或肝血不足,阴津匮乏... “肝为罢极之本”是指通过肝脏的调节,人体各脏腑组织及精气血津液运行皆弛张有度,无太过或不及,以维持中和的状态。若肝脏功能失调,影响全身气机枢转,可导致病理表现截然相反的五脏病变。如肝气疏泄不及,气滞肠腑,或肝血不足,阴津匮乏,会导致大便干结、秘而不通;肝气疏泄太过,横乘脾土,又可导致腹痛泄泻、大便稀溏。肝郁乘脾,脾虚生痰,会出现乏力懒言、多寐等症状;肝火亢盛,影响心神,可导致少寐、不寐。文章列举分析基于“肝为罢极之本”诊治的脾胃病泄泻案、便秘案和心系疾病不寐案、多寐案,旨在说明临床治疗心脾疾病时可以调肝为主,调整阴阳,补虚泻实,双向调节,使肝气无太过亦无不及,全身气血不急不怠,脏腑经络等恢复和合状态。 展开更多
关键词 肝为罢极之本 泄泻 便秘 不寐 多寐 心脾疾病
下载PDF
基于既病防变思想的健脾行气解毒法治疗中晚期原发性肝癌患者的效果
17
作者 李江艳 李阳 尹旭 《河南医学研究》 CAS 2024年第8期1487-1490,共4页
目的研究基于既病防变思想的健脾行气解毒法对中晚期原发性肝癌患者的作用效果。方法选取安阳市中医院2019年4月至2023年4月收治的80例中晚期原发性肝癌患者,随机分为对照组和观察组,对照组(40例)接受索拉非尼联合放疗,观察组(40例)联... 目的研究基于既病防变思想的健脾行气解毒法对中晚期原发性肝癌患者的作用效果。方法选取安阳市中医院2019年4月至2023年4月收治的80例中晚期原发性肝癌患者,随机分为对照组和观察组,对照组(40例)接受索拉非尼联合放疗,观察组(40例)联合基于既病防变思想的健脾行气解毒法治疗,对比两组中医证候积分、肝功能、肿瘤标志物水平、复发转移情况和不良反应发生率。结果治疗后,观察组谷草转氨酶(GOT)、谷丙转氨酶(GPT)、总胆红素(TBil)、细胞角蛋白19片段抗原21-1(CYFRA21-1)、甲胎蛋白(AFP)、糖类抗原199(CA199)水平均低于对照组(P<0.05),肿瘤复发转移率及中医证候积分低于对照组(P<0.05);两组不良反应发生率比较差异无统计学意义(P>0.05)。结论基于既病防变思想的健脾行气解毒法治疗中晚期原发性肝癌患者的效果确切,能够降低中医证候积分,改善肝功能,降低肿瘤标志物水平和肿瘤复发转移率,安全性高,具有临床推广价值。 展开更多
关键词 既病防变思想 健脾行气解毒法 中晚期原发性肝癌 肝功能
下载PDF
逍遥散联合水飞蓟素胶囊治疗肝郁脾虚证非酒精性脂肪性肝病临床研究
18
作者 苏林红 林军 +2 位作者 柳侠平 叶小丹 陈剑 《新中医》 CAS 2024年第7期42-46,共5页
目的:逍遥散联合水飞蓟素胶囊治疗肝郁脾虚证非酒精性脂肪性肝病(NAFLD)的疗效。方法:选取90例肝郁脾虚证NAFLD患者,按随机数字表法分为对照组及治疗组各45例。2组行非药物措施,对照组予以水飞蓟素胶囊口服,治疗组在对照组基础上加逍遥... 目的:逍遥散联合水飞蓟素胶囊治疗肝郁脾虚证非酒精性脂肪性肝病(NAFLD)的疗效。方法:选取90例肝郁脾虚证NAFLD患者,按随机数字表法分为对照组及治疗组各45例。2组行非药物措施,对照组予以水飞蓟素胶囊口服,治疗组在对照组基础上加逍遥散治疗。2组均连续治疗12周。比较2组临床疗效,比较2组治疗前后肝功能指标[谷草转氨酶(AST)、丙氨酸转氨酶(ALT)、谷氨酰转肽酶(GGT)]值、血脂指标[总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)]值、血清TLR4/NF-κB信号通路相关蛋白水平[血清TOLL样受体4(TLR4)、髓样分化因子88(MyD88)、核转录因子-κB(NF-κB)]、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)的变化。结果:治疗12周后,治疗组临床疗效总有效率为91.11%,对照组为73.33%,2组比较,差异有统计学意义(P<0.05)。治疗12周后,2组AST、ALT、GGT指标值均较治疗前下降(P<0.05),治疗组上述3项指标值均低于对照组(P<0.05)。治疗12周后,2组TC、TG、LDL-C水平均较治疗前下降(P<0.05),HDL-C水平均较治疗前上升(P<0.05);治疗组TC、TG、LDL-C水平均低于对照组(P<0.05),HDL-C水平高于对照组(P<0.05)。治疗12周后,2组血清TLR4、MyD88、NF-κB、IL-6、TNF-α水平均较治疗前下降(P<0.05),治疗组上述5项水平均低于对照组(P<0.05)。结论:逍遥散联合水飞蓟素胶囊对肝郁脾虚证NAFLD的疗效确切,可有效改善肝功能及血脂状况,调节血清TLR4-NF-κB信号通路,抑制炎症反应。 展开更多
关键词 非酒精性脂肪性肝病 肝郁脾虚证 逍遥散 水飞蓟素胶囊 血清TOLL样受体4 髓样分化因子88
下载PDF
升阳泻湿法治疗非酒精性脂肪性肝病初探
19
作者 李垚 许珂 +5 位作者 刘亚兰 钱彦艳 周鑫 李美瑾 罗明丽 廖冠宇 《光明中医》 2024年第6期1187-1190,共4页
非酒精性脂肪性肝病是目前的多发病,为多因素所致,严重影响公共健康,目前对于该病的证治报道较多。该病的临床表现多数不典型,病机证候复杂,笔者汲取李东垣理论思想中升发脾之清气,以及黄元御理论思想中泻湿疏木的治法,把二者进行优化组... 非酒精性脂肪性肝病是目前的多发病,为多因素所致,严重影响公共健康,目前对于该病的证治报道较多。该病的临床表现多数不典型,病机证候复杂,笔者汲取李东垣理论思想中升发脾之清气,以及黄元御理论思想中泻湿疏木的治法,把二者进行优化组合,拟定了升阳化湿,培土疏木为治疗大法运用于临床,立足于“湿”,分为“湿浊内蕴”和“脾虚湿困”2个证型,驭繁就简,取得了理想的临床疗效。 展开更多
关键词 胁痛 非酒精性脂肪性肝病 脾虚湿困证 升阳泻湿法 培土疏木法 戴氏经方医学流派
下载PDF
基于养正除积法运用杵针治疗肝郁脾虚型卒中后抑郁临床观察
20
作者 徐臻 李思娜 余金银 《中国中医药现代远程教育》 2024年第13期107-110,共4页
目的研究基于养正除积法探讨杵针对肝郁脾虚型卒中后抑郁患者的影响。方法选择2021年3月—2022年3月广东省第二中医院脑病科门诊和病房收治的肝郁脾虚型卒中后抑郁患者80例,随机分为试验组和对照组,每组40例。对照组采用基础治疗结合草... 目的研究基于养正除积法探讨杵针对肝郁脾虚型卒中后抑郁患者的影响。方法选择2021年3月—2022年3月广东省第二中医院脑病科门诊和病房收治的肝郁脾虚型卒中后抑郁患者80例,随机分为试验组和对照组,每组40例。对照组采用基础治疗结合草酸艾司西酞普兰治疗,试验组采用基础治疗结合杵针治疗,比较两组临床效果、汉密尔顿抑郁量表(HAMD)评分、脑卒中影响量表(SIS)评分及治疗依从性。结果试验组患者治疗总有效率为92.50%(37/40),高于对照组的75.00%(30/40),差异有统计学意义(P<0.05)。治疗后,试验组HAMD评分低于对照组,SIS评分及治疗总依从性高于对照组,差异有统计学意义(P<0.05)。结论基于养正除积法的杵针治疗可有效缓解肝郁脾虚型卒中后抑郁患者抑郁情绪,提高患者生活质量。 展开更多
关键词 中风 脑卒中 抑郁 肝郁脾虚证 杵针疗法 养正除积法
下载PDF
上一页 1 2 52 下一页 到第
使用帮助 返回顶部